This is a delivery order awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corporation, a leading manufacturer of medical devices. The $21,316.72 fixed-price contract is for the Eluvia Drug Eluting Stent, a specialized cardiovascular medical device. The contract has an ultimate completion date of December 12, 2024. Boston Scientific is the prime contractor and sole provider for this award, which is not associated with a set-aside program. The contract builds on Boston Scientific's broader role as a supplier of innovative medical technologies and services to federal healthcare agencies such as the Department of Veterans Affairs (VA) and the Defense Health Agency (DHA). In addition to direct contract awards, Boston Scientific also participates as a subrecipient on federal grant-funded research and development efforts, demonstrating its involvement in advancing cutting-edge medical solutions.
Generated 3/6/25, 10:01 AM